Cilofexor

≥99%

  • Product Code: 100088
  CAS:    1418274-28-8
Molecular Weight: 586.85 g./mol Molecular Formula: C₂₈H₂₂Cl₃N₃O₅
EC Number: MDL Number:
Melting Point: Boiling Point:
Density: Storage Condition: 2-8℃
Product Description: Cilofexor is primarily investigated for its potential therapeutic applications in liver diseases, particularly nonalcoholic steatohepatitis (NASH). It functions as a farnesoid X receptor (FXR) agonist, which plays a critical role in regulating bile acid, lipid, and glucose metabolism. By activating FXR, it helps reduce liver inflammation, fibrosis, and fat accumulation, making it a promising candidate for managing NASH. Additionally, its mechanism of action may also contribute to improving metabolic parameters, such as insulin sensitivity and cholesterol levels, in patients with liver-related metabolic disorders. Clinical trials are ongoing to evaluate its efficacy and safety in these conditions.
Sizes / Availability / Pricing:
Size (g) Availability Price Quantity
0.005 10-20 days ฿18,468.00
+
-
0.010 10-20 days ฿28,728.00
+
-
Cilofexor
Cilofexor is primarily investigated for its potential therapeutic applications in liver diseases, particularly nonalcoholic steatohepatitis (NASH). It functions as a farnesoid X receptor (FXR) agonist, which plays a critical role in regulating bile acid, lipid, and glucose metabolism. By activating FXR, it helps reduce liver inflammation, fibrosis, and fat accumulation, making it a promising candidate for managing NASH. Additionally, its mechanism of action may also contribute to improving metabolic parameters, such as insulin sensitivity and cholesterol levels, in patients with liver-related metabolic disorders. Clinical trials are ongoing to evaluate its efficacy and safety in these conditions.
Mechanism -
Appearance -
Longevity -
Strength -
Storage -
Shelf Life -
Allergen(s) -
Dosage (Range) -
Dosage (Per Day) -
Mix Method -
Heat Resistance -
Stable in pH range -
Solubility -
Product Types -
INCI -

Cart

No products

Subtotal: ฿0.00
฿0.00 Total :